Association between Vitamin D Receptor Gene Polymorphisms and Response to Treatment of Pulmonary Tuberculosis
Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. Methods. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with...
Saved in:
Published in | The Journal of infectious diseases Vol. 190; no. 5; pp. 920 - 927 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chicago, IL
The University of Chicago Press
01.09.2004
University of Chicago Press Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. Methods. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB. Results. Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88–9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study. Conclusions. VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. |
---|---|
AbstractList | Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. Methods. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB. Results. Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88–9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study. Conclusions. VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. Methods. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and foci polymorphisms were compared among 103 patients with pulmonary TB and 20b matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB. Results. Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the foci FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88-9.75; P = .001). VDR poly morphisms were not significantly associated with susceptibility to TB in the case-control study. Conclusions. VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB. Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88-9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study. VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB. Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88-9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study. VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. Methods. In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB. Results. Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88-9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study. Conclusions. VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection.BACKGROUNDPolymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection.In a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB.METHODSIn a Peruvian community with a high incidence of tuberculosis (TB), VDR TaqI and FokI polymorphisms were compared among 103 patients with pulmonary TB and 206 matched healthy control subjects. Associations of VDR polymorphisms with treatment outcome were analyzed among 78 patients undergoing treatment of pulmonary TB.Sputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88-9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study.RESULTSSputum mycobacterial culture and auramine stain conversions were significantly faster among participants with the FokI FF genotype, compared with participants with the non-FF genotypes. Sputum culture conversion was faster among participants with the TaqI Tt genotype, compared with those with the TT genotype. Increased probability of culture conversion during TB treatment was independently associated with the TaqI Tt genotype (age- and sex-adjusted relative risk, 4.28; 95% confidence interval, 1.88-9.75; P = .001). VDR polymorphisms were not significantly associated with susceptibility to TB in the case-control study.VDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB.CONCLUSIONSVDR gene polymorphisms are associated with the time to sputum culture and auramine stain conversion during TB treatment. To our knowledge, the present study is the first report of a specific host gene influence on the outcome of TB treatment. These findings demonstrate the potential clinical relevance of immunomodulatory functions of vitamin D metabolites acting via the VDR in the host response against pulmonary TB. |
Author | Roth, Daniel E. Cabrera, Lilia Rodriguez, Richard Soto, Giselle Arenas, Fanny Ortiz, Jaime Bautista, Christian T. Gilman, Robert H. |
Author_xml | – sequence: 1 givenname: Daniel E. surname: Roth fullname: Roth, Daniel E. organization: Asociación Benéfica Proyectos en Informática, Salud, Medicina y Agricultura, Lima, Peru – sequence: 2 givenname: Giselle surname: Soto fullname: Soto, Giselle organization: Asociación Benéfica Proyectos en Informática, Salud, Medicina y Agricultura, Lima, Peru – sequence: 3 givenname: Fanny surname: Arenas fullname: Arenas, Fanny organization: Tuberculosis Research Laboratory, Department of Microbiology, Cayetano Heredia University, Lima, Peru – sequence: 4 givenname: Christian T. surname: Bautista fullname: Bautista, Christian T. organization: Asociación Benéfica Proyectos en Informática, Salud, Medicina y Agricultura, Lima, Peru – sequence: 5 givenname: Jaime surname: Ortiz fullname: Ortiz, Jaime organization: Hospital de Apoyo Maria Auxiliadora, Lima, Peru – sequence: 6 givenname: Richard surname: Rodriguez fullname: Rodriguez, Richard organization: Hospital de Apoyo Maria Auxiliadora, Lima, Peru – sequence: 7 givenname: Lilia surname: Cabrera fullname: Cabrera, Lilia organization: Asociación Benéfica Proyectos en Informática, Salud, Medicina y Agricultura, Lima, Peru – sequence: 8 givenname: Robert H. surname: Gilman fullname: Gilman, Robert H. email: rgilman@prisma.org.pe organization: Asociación Benéfica Proyectos en Informática, Salud, Medicina y Agricultura, Lima, Peru |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16099080$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15295697$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0V1rFDEYBeAgFbut-g-UKOiVo_mYSSaXpXVbsWAti5TehEzmHZx1JhmTDLb_3pRdu1ARr3JxHkJyzgHac94BQs8peU9JLT6UjDPKHqEFrbgshKB8Dy0IYaygtVL76CDGNSGk5EI-Qfu0YqoSSi7QeBSjt71JvXe4gfQLwOFvfTJj7_AJvgQLU_IBn4IDfOGH29GH6Xsfx4iNa3MeJ-8i4OTxKoBJI7iEfYcv5mH0zoRbvJobCHYefOzjU_S4M0OEZ9vzEK2WH1fHZ8X5l9NPx0fnhS05SYUsTVt2pGyNEqwTjWEdB854XXa05aAkbUGCqFtoLGsq6GwlRNWCLYkRVvBD9HZz7RT8zxli0mMfLQyDceDnqIWQuaBK_hfSOjfGlMrw9QO49nNw-Q-aMa6IlBXN6OUWzc0IrZ5CP-YG9J-2M3izBSZaM3TBONvHnRNEKVKT3bNs8DEG6HaE6Lu59WbuDN89gDZPd7dlCqYf_uavNtzP07-vfLEx65h3v1ecEClqwXNebPI-Jri5z034oYXkstJnV9f6cvn1syyvr_SS_wb-nM1v |
CODEN | JIDIAQ |
CitedBy_id | crossref_primary_10_1371_journal_pone_0140634 crossref_primary_10_1042_BSR20204102 crossref_primary_10_1139_cjpp_2014_0386 crossref_primary_10_1016_S1473_3099_12_70275_X crossref_primary_10_1155_2010_324719 crossref_primary_10_3389_fpubh_2022_934106 crossref_primary_10_3390_antibiotics10111354 crossref_primary_10_3892_br_2014_402 crossref_primary_10_1007_s12639_019_01159_7 crossref_primary_10_1155_2015_598605 crossref_primary_10_1097_FPC_0b013e328354455c crossref_primary_10_1007_s00467_011_2000_0 crossref_primary_10_1111_j_1440_1711_2006_01420_x crossref_primary_10_1016_j_clnesp_2019_03_001 crossref_primary_10_1097_CM9_0000000000000554 crossref_primary_10_1136_bmjopen_2020_039935 crossref_primary_10_2174_1573398X16999200626160349 crossref_primary_10_1007_s00408_015_9789_4 crossref_primary_10_4049_jimmunol_181_10_7090 crossref_primary_10_2174_1573399817666210902144539 crossref_primary_10_1016_j_meegid_2011_02_017 crossref_primary_10_1179_1973947815Y_0000000043 crossref_primary_10_1371_journal_pone_0267917 crossref_primary_10_2217_pgs_2017_0176 crossref_primary_10_3390_ijms26051848 crossref_primary_10_1172_JCI30142 crossref_primary_10_1038_s41397_017_0005_1 crossref_primary_10_1186_1475_2891_9_41 crossref_primary_10_1097_MD_0000000000002256 crossref_primary_10_1186_s12879_015_1196_1 crossref_primary_10_1177_1753425919842643 crossref_primary_10_1097_MAJ_0b013e3182070f47 crossref_primary_10_1016_j_ijid_2009_05_001 crossref_primary_10_1016_j_medcli_2013_09_036 crossref_primary_10_1371_journal_pone_0083843 crossref_primary_10_1093_infdis_jiu121 crossref_primary_10_1371_journal_pone_0180916 crossref_primary_10_1111_j_1365_2249_2011_04381_x crossref_primary_10_1080_10408398_2012_679500 crossref_primary_10_1371_journal_pone_0175400 crossref_primary_10_1016_S0140_6736_07_61262_8 crossref_primary_10_1080_17476348_2017_1354700 crossref_primary_10_1016_j_dsx_2012_02_021 crossref_primary_10_1016_j_tube_2010_02_002 crossref_primary_10_3109_14767058_2012_746304 crossref_primary_10_1002_jcla_22562 crossref_primary_10_1016_j_ejcdt_2016_03_004 crossref_primary_10_1016_j_meegid_2012_05_011 crossref_primary_10_1016_j_tube_2007_03_001 crossref_primary_10_1128_IAI_00353_08 crossref_primary_10_1096_fj_06_7261com crossref_primary_10_2217_pgs_15_10 crossref_primary_10_1111_sji_12127 crossref_primary_10_1016_j_tube_2016_02_007 crossref_primary_10_1111_iji_12340 crossref_primary_10_3390_ijms23073860 crossref_primary_10_1016_j_intimp_2017_06_010 crossref_primary_10_1080_07853890_2024_2407066 crossref_primary_10_4161_derm_2_1_12488 crossref_primary_10_1111_j_1600_051X_2005_00806_x crossref_primary_10_1186_s12879_015_1018_5 crossref_primary_10_2217_fmb_13_164 crossref_primary_10_1017_S1446545000000488 crossref_primary_10_1016_S0140_6736_10_61889_2 crossref_primary_10_1111_j_1399_0012_2011_01523_x crossref_primary_10_1016_j_tube_2007_01_001 crossref_primary_10_1111_j_1574_695X_2009_00600_x crossref_primary_10_1155_2024_9978076 crossref_primary_10_1590_S0100_879X2009000400002 crossref_primary_10_1111_j_1600_0757_2011_00415_x crossref_primary_10_1111_j_1440_1843_2009_01690_x crossref_primary_10_1007_s10753_015_0150_0 crossref_primary_10_1016_j_cca_2006_02_016 crossref_primary_10_1017_S0029665111003326 crossref_primary_10_1155_2021_9947370 crossref_primary_10_1186_s12879_016_1699_4 crossref_primary_10_1128_microbiolspec_TBTB2_0011_2016 crossref_primary_10_1210_er_2018_00126 crossref_primary_10_3389_fgene_2024_1382957 crossref_primary_10_1002_jmv_26707 crossref_primary_10_31146_1682_8658_ecg_216_8_151_166 crossref_primary_10_1086_596658 crossref_primary_10_1093_infdis_jiu259 crossref_primary_10_1016_j_ijtb_2022_05_011 crossref_primary_10_1016_j_meegid_2021_104871 crossref_primary_10_1016_j_gene_2012_11_017 crossref_primary_10_1186_1824_7288_38_25 crossref_primary_10_1111_j_1753_4887_2009_00195_x crossref_primary_10_1186_s12903_019_0715_7 crossref_primary_10_3109_07853890_2010_543923 crossref_primary_10_1007_s11904_014_0218_8 crossref_primary_10_1016_j_ijantimicag_2016_07_010 crossref_primary_10_1016_j_ijtb_2018_04_005 crossref_primary_10_1016_j_medcle_2015_05_003 crossref_primary_10_1080_14787210_2022_2081546 crossref_primary_10_1016_S1000_1948_11_60028_2 |
ContentType | Journal Article |
Copyright | Copyright 2004 Infectious Diseases Society of America 2004 by the Infectious Diseases Society of America 2004 2004 INIST-CNRS Copyright University of Chicago Press Sep 1, 2004 |
Copyright_xml | – notice: Copyright 2004 Infectious Diseases Society of America – notice: 2004 by the Infectious Diseases Society of America 2004 – notice: 2004 INIST-CNRS – notice: Copyright University of Chicago Press Sep 1, 2004 |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM K9. NAPCQ 7QL C1K 7X8 |
DOI | 10.1086/423212 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Bacteriology Abstracts (Microbiology B) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1537-6613 |
EndPage | 927 |
ExternalDocumentID | 965820991 15295697 16099080 10_1086_423212 10.1086/423212 30076863 ark_67375_HXZ_RFQK74ZX_F |
Genre | Research Support, Non-U.S. Gov't Journal Article General Information |
GeographicLocations | Peru |
GeographicLocations_xml | – name: Peru |
GroupedDBID | --- -DZ -~X ..I .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 123 1TH 29K 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 70D 85S AABZA AACGO AACZT AAHBH AAHTB AAJKP AAJQQ AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWTL ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPEJ ABPLY ABPPZ ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACGOD ACHIC ACPRK ACUFI ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFHKK AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BR6 BSCLL BTRTY BVRKM C45 CDBKE CS3 CZ4 D-I DAKXR DCCCD DIK DILTD DU5 D~K EBS ECGQY EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HQ3 HTVGU HW0 HZ~ IH2 IOX IPSME J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LSO LU7 MHKGH MJL ML0 MVM N4W N9A NEJ NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TR2 W2D W8F WH7 X7H X7M Y6R YAYTL YKOAZ YXANX ZGI ZXP ~91 AAYOK AASNB ADACV ADJQC ADRIX AFXEN DOOOF ESX JSODD M49 1KJ 3O- 41~ AAFWJ AAPGJ AAWDT AAYXX ABDPE ABSMQ ACFRR ACPQN ACUTJ ACVCV ACZBC ADMTO AEKPW AFFQV AFQQW AFSHK AGKRT AGMDO AHGBF AI. AJDVS APJGH AQDSO AQKUS AVNTJ BZKNY CITATION EIHJH H13 MBLQV OBFPC O~Y P0- TMA VH1 ZE2 IQODW CGR CUY CVF ECM EIF NPM VXZ YIF K9. NAPCQ 7QL C1K 7X8 |
ID | FETCH-LOGICAL-c430t-74ad4f04da962f6ba2f3e32384f1d3e971de7e68debc2b5efc5665dec40a6c63 |
ISSN | 0022-1899 |
IngestDate | Sun Aug 24 09:28:50 EDT 2025 Fri Jul 11 12:24:12 EDT 2025 Fri Jul 25 19:34:41 EDT 2025 Wed Feb 19 01:54:43 EST 2025 Mon Jul 21 09:12:54 EDT 2025 Tue Jul 01 03:23:40 EDT 2025 Thu Apr 24 23:11:33 EDT 2025 Wed Sep 11 04:50:45 EDT 2024 Fri Jun 20 02:31:54 EDT 2025 Tue Aug 05 16:48:51 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Infection Lung disease Treatment Gene Microbiology Vitamin D Respiratory disease Pulmonary tuberculosis Bacteriosis Mycobacterial infection Polymorphism |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c430t-74ad4f04da962f6ba2f3e32384f1d3e971de7e68debc2b5efc5665dec40a6c63 |
Notes | ark:/67375/HXZ-RFQK74ZX-F Present affiliations: Department of Pediatrics and Child Health, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada (D.E.R.); US Military HIV Research Program, Henry M. Jackson Foundation, Rockville, Maryland (C.T.B.). istex:83CF622E49421D4B560286CB192768BF767AC3B6 SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 15295697 |
PQID | 223907751 |
PQPubID | 41591 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_66761357 proquest_miscellaneous_18043299 proquest_journals_223907751 pubmed_primary_15295697 pascalfrancis_primary_16099080 crossref_primary_10_1086_423212 crossref_citationtrail_10_1086_423212 oup_primary_10_1086_423212 jstor_primary_30076863 istex_primary_ark_67375_HXZ_RFQK74ZX_F |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-09-01 |
PublicationDateYYYYMMDD | 2004-09-01 |
PublicationDate_xml | – month: 09 year: 2004 text: 2004-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Chicago, IL |
PublicationPlace_xml | – name: Chicago, IL – name: United States – name: Oxford |
PublicationTitle | The Journal of infectious diseases |
PublicationTitleAbbrev | J Infect Dis |
PublicationTitleAlternate | J Infect Dis |
PublicationYear | 2004 |
Publisher | The University of Chicago Press University of Chicago Press Oxford University Press |
Publisher_xml | – name: The University of Chicago Press – name: University of Chicago Press – name: Oxford University Press |
SSID | ssj0004367 |
Score | 2.2027652 |
Snippet | Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection.... Background. Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection.... Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. In a Peruvian... Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis infection. In a Peruvian... Polymorphisms in the gene that encodes the vitamin D receptor (VDR) may influence the host response to Mycobacterium tuberculosis... |
SourceID | proquest pubmed pascalfrancis crossref oup jstor istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 920 |
SubjectTerms | Adolescent Adult Alleles Antitubercular Agents - therapeutic use Bacteria Biological and medical sciences Case control studies Cohort studies Deoxyribonucleases, Type II Site-Specific Fundamental and applied biological sciences. Psychology Genetic Predisposition to Disease Genotypes Humans Incidence Infectious diseases Medical sciences Microbiology Middle Aged Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Peru Polymorphism, Genetic Prospective Studies Pulmonary tuberculosis Receptors Receptors, Calcitriol - genetics Sputum Treatment Outcome Tuberculosis Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - epidemiology Tuberculosis, Pulmonary - genetics Vitamin D |
Title | Association between Vitamin D Receptor Gene Polymorphisms and Response to Treatment of Pulmonary Tuberculosis |
URI | https://api.istex.fr/ark:/67375/HXZ-RFQK74ZX-F/fulltext.pdf https://www.jstor.org/stable/30076863 https://www.ncbi.nlm.nih.gov/pubmed/15295697 https://www.proquest.com/docview/223907751 https://www.proquest.com/docview/18043299 https://www.proquest.com/docview/66761357 |
Volume | 190 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbKJtAkhGAwlg2GH4CXqlMTO07yiBhdBRoSUKRqL5GTOFJFm1RNghh_PXd2fpVRCXiJqthyUt_n013uuztCXjLuMxbxdOR4iRrxKIUjJbHgpcuFHyRuIjkmCl99FNOv_P3cnQ8GNz3WUlVG5_HPP-aV_I9U4R7IFbNk_0Gy7aJwA36DfOEKEobrX8m4t7ct4eo7OPurRTa8GIIuU2twqbFLssJuDODmw64uipWpy7wx9FjdO6PjmyMDulrCX0A6XVlFahNXy7xYFH0ztksoq2tOGEZXVTQBn45Bn5sPNyaVvct7-JLr_k3DS2z3tOzhTmUmxQzrCnfJFhJ2sTZ0TTkE1EuzrU8WvOVk9VMIbN90RmrVsGkbWuPN7SnVQKfL3Vb2Yx17wkizYWL3JL5eaZHbGMYUhgD8W1ntZugO2XfAw8DmF5fzjh3EmfCaQvP4pr22VOaBpp-TXmLLpNnH0_mjYbc2aZP317KAM5eaZim7vRlt1cwekge1DOkbg61HZKCyQ3LXNCi9OST3rmrqxWOy6oGN1mCjNdjoBW3ARhFsdAtsFMBGG7DRMqct2Gie0hZstA-2J2Q2eTd7Ox3VvTpGMWfjcuRxmfB0zBMZCCcVkXRSphjYgzy1E6YCz06Up4SfqCh2IlelMfgRbqJiPpYiFuyI7GV5po4JjUWaSl86vorB3YiUzwEZLPCjREYqsJVFXjW7HcZ1HXtsp7IMNZ_CF6ERkEVetPPWpnLLrRmvtbDaYbn5hjxHzw2n8-vw8-TTB49fz8OJRY60NNuJTAewBbPICYh35_JnW1LvpgmMRvtji5w2MAhrrVKEYK4HWJbShvdvR0HlYxxPZgpOcmj7WEczCHbPQOK6zVzPIk8Nurpn15g92TlySg66M_uM7JWbSj0Hw7uMzvQR-QXd59r2 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+vitamin+D+receptor+gene+polymorphisms+and+response+to+treatment+of+pulmonary+tuberculosis&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Roth%2C+Daniel+E&rft.au=Soto%2C+Giselle&rft.au=Arenas%2C+Fanny&rft.au=Bautista%2C+Christian+T&rft.date=2004-09-01&rft.issn=0022-1899&rft.volume=190&rft.issue=5&rft.spage=920&rft_id=info:doi/10.1086%2F423212&rft_id=info%3Apmid%2F15295697&rft.externalDocID=15295697 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon |